Tg Therapeutics Stock Price on February 27, 2024
| TGTX Stock | USD 15.88 2.22 16.25% |
Below is the normalized historical share price chart for TG Therapeutics extending back to May 03, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TG Therapeutics stands at 15.88, as last reported on the 2nd of May, with the highest price reaching 18.00 and the lowest price hitting 14.87 during the day.
If you're considering investing in TGTX Stock, it is important to understand the factors that can impact its price. We consider TG Therapeutics somewhat reliable. TG Therapeutics retains Efficiency (Sharpe Ratio) of 0.0097, which indicates the firm had a 0.0097% return per unit of price deviation over the last 3 months. We have found twenty-three technical indicators for TG Therapeutics, which you can use to evaluate the volatility of the company. Please validate TG Therapeutics' Risk Adjusted Performance of (0.01), mean deviation of 2.4, and Standard Deviation of 4.26 to confirm if the risk estimate we provide is consistent with the expected return of 0.0467%.
At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 155.9 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 74.7 K in 2024. . At this time, TG Therapeutics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 15.86 in 2024, whereas Price To Sales Ratio is likely to drop 9.86 in 2024. TGTX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of December 1995 | 200 Day MA 13.3993 | 50 Day MA 15.0336 | Beta 2.317 |
TGTX |
Sharpe Ratio = 0.0097
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TGTX |
Estimated Market Risk
| 4.82 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TG Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TG Therapeutics by adding TG Therapeutics to a well-diversified portfolio.
Price Book 13.6235 | Enterprise Value Ebitda 79.6891 | Price Sales 9.358 | Shares Float 134.9 M | Wall Street Target Price 30.43 |
TG Therapeutics Valuation on February 27, 2024
It is possible to determine the worth of TG Therapeutics on a given historical date. On February 27, 2024 TGTX was worth 13.82 at the beginning of the trading date compared to the closed value of 13.91. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TG Therapeutics stock. Still, in general, we apply an absolute valuation method to find TG Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TG Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TG Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.50 | 13.73 | 13.00 | 13.36 | 4,993,153 | |
02/27/2024 | 13.82 | 14.07 | 13.35 | 13.91 | 6,048,887 |
| 16.18 | 18.89 | 15.90 | 17.63 | 16,644,190 |
| Backtest TG Therapeutics | | | TG Therapeutics History | | | TG Therapeutics Valuation | Previous | Next |
TG Therapeutics Trading Date Momentum on February 27, 2024
| On February 28 2024 TG Therapeutics was traded for 17.63 at the closing time. The top price for the day was 18.89 and the lowest listed price was 15.90 . The trading volume for the day was 16.6 M. The trading history from February 28, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 26.74% . The trading price change against the current closing price is 30.91% . |
TG Therapeutics Fundamentals Correlations and Trends
By evaluating TG Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TG Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TGTX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TG Therapeutics Stock history
TG Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TGTX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TG Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TG Therapeutics stock prices may prove useful in developing a viable investing in TG Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 148.5 M | 155.9 M | |
| Net Loss | -164.4 M | -172.6 M |
TG Therapeutics Quarterly Net Working Capital |
|
TG Therapeutics Stock Technical Analysis
TG Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TG Therapeutics Period Price Range
Low | February 27, 2024
| High |
13.82 | 13.91 |
TG Therapeutics May 2, 2024 Market Strength
Market strength indicators help investors to evaluate how TG Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TG Therapeutics shares will generate the highest return on investment. By undertsting and applying TG Therapeutics stock market strength indicators, traders can identify TG Therapeutics entry and exit signals to maximize returns
TG Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TG Therapeutics' price direction in advance. Along with the technical and fundamental analysis of TGTX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TGTX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.48) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TG Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for TGTX Stock analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is TG Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TG Therapeutics. If investors know TGTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TG Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.09 | Revenue Per Share 1.646 | Quarterly Revenue Growth 548.638 | Return On Assets 0.0493 | Return On Equity 0.1157 |
The market value of TG Therapeutics is measured differently than its book value, which is the value of TGTX that is recorded on the company's balance sheet. Investors also form their own opinion of TG Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is TG Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TG Therapeutics' market value can be influenced by many factors that don't directly affect TG Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TG Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TG Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TG Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.